Literature DB >> 25909065

Association of ABO and Rh Blood Groups to Blood-Borne Infections among Blood Donors in Tehran-Iran.

Fatemeh Mohammadali1, Aliakbar Pourfathollah2.   

Abstract

BACKGROUND: The aim of this study was to investigate the prevalence of hepatitis B, hepatitis C, HIV and syphilis infections in blood donors referred to Tehran Blood Transfusion Center (TBTC), and determine any association between blood groups and blood- borne infections between the years of 2005 and 2011.
METHODS: This was a retrospective study conducted at TBTC. All of the donor serum samples were screened for HBV, HCV, HIV and syphilis by using third generation ELISA kits and RPR test. Initial reactive samples were tested in duplicate. Confirmatory tests were performed on all repeatedly reactive donations. Blood group was determined by forward and reverse blood grouping. The results were subjected to chi square analysis for determination of statistical difference between the values among different categories according to SPSS program.
RESULTS: Overall, 2031451 donor serum samples were collected in 2005-2011. Totally, 10451 were positive test for HBV, HCV, HIV and syphilis. The overall seroprevalence of HBV, HCV, HIV, and syphilis was 0.39%, 0.11%, 0.005%, and 0.010%, respectively. Hepatitis B and HIV infections were significantly associated with blood group of donors (P <0.05) ; percentage of HIV Ag/Ab was higher in donors who had blood group "A" and percentage of HBs Ag was lower in donors who had blood group O. There was no significant association between Hepatitis C and syphilis infections with ABO and Rh blood groups (P>0.05).
CONCLUSION: Compared with neighboring countries and the international standards, prevalence of blood-borne infections is relatively low.

Entities:  

Keywords:  ABO Blood groups; Blood donors; HBV; HCV; HIV; Rhesus (Rh); Syphilis

Year:  2014        PMID: 25909065      PMCID: PMC4401062     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


Introduction

The surface of red blood cells contains different polysaccharides and proteins called blood group antigens. Approximately 700 erythrocyte antigens are discovered and part of them that are related to each other described into 33 blood group systems by the International Society of Blood Transfusion (TBTC), of which ABO and Rh groups system are the most important (1-3). “Blood group antigens plays a vital role in transfusion safety, understanding genetics, inheritance pattern, researching population migration patterns, as well as resolving certain medico-legal issues” (1,4). In modern medicine besides their importance in evolution, their relation to disease and environment is being increasingly important. Some blood groups can act as a receptor and ligand for bacteria, parasites and viruses. “The possible pathogenesis for this susceptibility is that as many organisms that may bind to polysaccharide on cells and soluble blood group antigens may block this binding” (5, 6). Several studies investigated the association of blood groups with infectious and non-infectious diseases. Among infectious disease, Human immunodeficiency virus (HIV), and Hepatitis virus are of great concern because of their prolonged viraemia and carrier or latent state. They also cause fatal, chronic and life-threatening disorders. AIDS in human was first reported in 1981 in USA and HIV was first isolated in 1983 (7, 8). HIV has infected more than 33 million people thus far worldwide and infection rates continue to increase (9). Infection with hepatitis B and hepatitis C are also the major health problems worldwide. There are about 2 billion people infected by HBV and among them more than 240 million have chronic (long-term) liver infections (10). It is estimated that 150 million people are chronically infected with HCV and 3 – 4 million are newly infected each year (11). Syphilis is also a systemic disease caused by Treponema pallidum (12). The world health organization (WHO) estimates that 12 million new cases of syphilis occur each year (13). Despite the fact that T. pallidum cannot survive in properly stored blood and the inescapable cost implications of syphilis testing of blood donors particularly in resource-poor settings, it must be noted that the emphasis of blood transfusion should be on two fundamental objectives – safety and protection of human lives. “Syphilis screening of donated blood, no matter what the incidence is in the donor population, has been considered to have value as a ‘lifestyle’ indicator, as individuals exposed to syphilis may also have been exposed to other sexually transmitted diseases”(14). Several studies have assessed the association of blood groups with blood-borne infections but based on different sample size, test methodology, covered age, social risk factors and geographic conditions, results have been different. The aim of this study was to investigate the prevalence of hepatitis B, Hepatitis C, HIV and Syphilis infections in blood donors referred to Tehran Blood Transfusion Center, with a population of over 300,000 blood donations per year, and to determine any association between blood groups and blood borne infections during 2005-2011 years.

Materials and Methods

This was a retrospective study conducted at TBTC. All blood donors who eligible to donated blood from 2005 to 2011 were reviewed. Donors who selected by the medical screening based on standard criteria for blood donation, participate into this study. 2031451 donors were eligible to donate blood. The volunteer donors constituted 100% of total blood donors. All of the eligible donor serum samples were screened for HBV, HCV, HIV and syphilis. Hepatitis B surface Antigen (HBS Ag), HIV (Ag/Ab) and HCV Ab screened using third generation ELISA kits. Serum from all donors was tested for the presence of Treponemal antibodies using Rapid Plasma Reagin test (RPR). Initial reactive samples were tested in duplicate. Repeatedly reactive results were considered sero-positive for their infections. Confirmatory tests were performed on all repeatedly reactive donations using the following tests: HBC Ab and HBS Ag confirmatory assay for HBS Ag positive samples, HCV RIBA for HCV Ab positive samples, HIV Western Blot for HIV Ag/Ab positive samples and FTA-ABS for RPR positive samples. Blood group was determined by forward blood grouping (cell grouping) and reverse blood grouping (serum grouping) by test tube agglutination method. Final blood group is confirmed only if both cell type and back type are identical. Rh negative blood groups were confirmed by antiglobulin technique. All weak D (DU) groups were considered as Rh positive. Data on the prevalence of blood-borne infections and the frequency of blood groups of donors was collected from MAK database (software with functionality to the blood banking and blood transfusion Centers that used in TBTC). Statistical analysis was carried out using SPSS software. Chi-square test was performed for Qualitative comparison. P value less than 0.05 was considered statistically significant.

Results

Over a period of six years (March 2005 to March2011) a total of 2,031,451 donations were collected with an average of 338,575 donations per year. 1,892,835(93.2%) of them were male and 138,616(6.8%) were female. After excluding of Blood group discrepancies, blood group of 2,028,086 donors was determined. Blood group O+ with frequency of 665,943 (32.8%) was commonest and Oh - with frequency of 1 donor (0.00004%) was least frequent among blood donors (Fig. 1). the prevalence of Rh positive and Rh negative was, 89.3% and 10.7%, respectively.
Fig. 1

Frequency of blood groups among blood donors referred to Tehran Blood Transfusion Center during 2005-2011

Out of the total blood donors results were positive for one or more infectious disease tests (HBV, HCV, HIV and syphilis) in 10476 donors, 9918 (95%) were males and 558 (5%) were females with male to female ratio of 17.7:1. Mean age of blood donors with positive test results was 38± 10.5 years. The overall prevalence of HBS Ag, anti-HCV, HIV Ag/Ab, and syphilis antibody were 0.39%, 0.11%, 0.005%, and 0.010%, respectively (Table 1).
Table 1

Frequency of Hepatitis B, Hepatitis C, HIV and Syphilis among blood donors by Year

YearNumber Of donorsHBV positiveHCV positiveHIV positiveSyphilis positive
Count%Count%Count%Count%
2005-200630395117450.573420.11130.004230.008
2006-200731420314250.453280.10100.003120.004
2007-200835121514750.424970.14220.006520.015
2008-200935190112360.354040.11200.006820.023
2009-201034126010380.303580.10130.004240.007
2010-20113689219320.253510.09300.008190.005
total203145178510.3922800.111080.0052120.010
*The difference between these numbers with the numbers of Table 1 is due to Discrepancy cases (Table 2)
Table 2

Frequency of Hepatitis B, Hepatitis C, HIV and Syphilis positivity according to blood group types 2005-2011

Blood GroupDonors (n)HBV positiveHCV positiveHIV positiveSyphilis positive
n(%)n(%)n(%)n(%)
O positive6659432396(0.36)705(0.11)28(0.004)61(0.009)
A positive5729992322(0.40)686(0.12)40(0.007)55(0.009)
B positive4334721766(0.41)510(0.12)14(0.003)61(0.014)
AB positive138444575(0.42)148(0.11)9(0.006)15(0.011)
Oh positive17----
O negative82423311(0.38)99(0.12)4(0.005)7(0.008)
A negative68379231(0.34)65(0.09)8(0.011)8(0.012)
B negative50325186(0.37)46(0.09)4(0.008)4(0.008)
AB negative1608352(0.32)14(0.09)--
Oh negative1----
Total20280867839(0.39)2273(0.11)107(0.005)211(0.010)
Discrepancy cases334412711
Total20314307851228010812
Table 2 shows the group wise distribution of Hepatitis B, Hepatitis C, HIV and syphilis. The prevalence of Hepatitis B, Hepatitis C, HIV and syphilis according to Rh status is given in Table 3.
Table 3

Frequency of Hepatitis B, Hepatitis C, HIV and syphilis positivity according to Rh status 2005-2011

Blood GroupNO. of DonorsHBV positiveHCV positiveHIV positiveSyphilis positive
n(%)n(%)n(%)n(%)
Rh D positive18108757059(0.39)2049(0.11)91(0.005)192(0.011)
Rh D negative217211780(0.36)224(0.10)16(0.007)19(0.009)
Total20280867839*(0.39)2273*(0.11)107*(0.005)211*(0.010)
Frequency of blood groups among blood donors referred to Tehran Blood Transfusion Center during 2005-2011 Frequency of Hepatitis B, Hepatitis C, HIV and Syphilis among blood donors by Year Frequency of Hepatitis B, Hepatitis C, HIV and Syphilis positivity according to blood group types 2005-2011 Frequency of Hepatitis B, Hepatitis C, HIV and syphilis positivity according to Rh status 2005-2011 In HBV positive donors, a significant association between blood groups (P =0.001, X2=31.902) and Rh status (P=0.029, X2 =4.752) was observed. Percentage of HBS Ag was found to be lower in donors who has blood group “O” and was higher among Rh positive donors. In HIV positive donors, a significant association between “A” blood group and HIV infection was observed (P =0.032, X2=15.346), but there was no significant association between HIV infection and Rh status (P =0.156, X2=2.015). In HCV positive donors, there was no Significant association between Hepatitis C infection and ABO blood groups system (P =0.104,X2=11.887) or Rh status (P =0.187, X2=1.741) In syphilis positive donors, There was no significant association between syphilis infection and ABO blood groups (P =0.229, X2= 9.345) or Rh status (P =0.423, X2 =0.642)

Discussion

After the discovery of blood groups, numerous studies on associations of blood groups and various diseases were performed. Identifying the prognostic and associating factors, which predict the condition of the disease and its response to the treatment, can play an important role in determining the therapeutic strategies. This study demonstrated that blood group O+ was commonest and Oh - was least frequent among blood donors. This is in agreement with the studies that performed on blood donors (15) and population of Tehran Province (16). In the current study, the overall prevalence of hepatitis b, hepatitis C, HIV and syphilis infections was 0.39%, 0.11%, 0.005%, and 0.010 %, respectively. Compared with neighboring countries and the international standards this level of prevalence is relatively low (17-25). The prevalence of all infections was lower among females, maybe females made a smaller section of blood donors in Iran, (only 6% of Iranian blood donors) (26) because they were found to be anemic and did not fulfill the required fitness criteria or maybe, as mentioned in many studies, women were reported as a healthier source of blood in the community (27). In our study, HBV prevalence among blood donors showed a downward trend over the period of six years. It seems that, vaccination against HBV among all of neonates since 1992 and selected groups such as health care workers, pregnant women, families of HBs Ag positive donors, multi-transfused patients and their families, progress in the recruitment of a safer donor population, confidential unit exclusion (CUE) applying, computerized data registry of blood donors, increase public knowledge about blood-borne infections and routes of transmission, may also have contributed to the observed decline (28). Overall, the prevalence of HCV decreased in six years however, fluctuated during the period under study, peaking in 2007. Such variation could be as a result of a combination of several factors including a change in screening reagent used, actual changes in population risks, changes in basic population which donor recruitment was done from that, or effectiveness of prospective donor screening measures (29). But it should be noted that people who may have been infected in the past years may identify in this year. HIV and RPR trends were shown a similar pattern, but RPR confirmed rates over the time were shown more rapid than HIV confirm results. It is essential to watch HIV after observing the raising pattern of syphilis due to changes in high risk behaviors in the community. It should be noted that the results of our study does not necessarily reflect the results of community because population of blood donors are predefined groups and most of them are in the sexually active age group. So far, in several studies the association of specific blood groups to certain diseases has been investigated. Prevalence of cardiovascular disease, ischemic heart disease, venous thrombosis, atherosclerosis, squamous cell carcinoma and basal cell carcinoma is higher in individuals with non-O blood groups (30-34). B antigen links with increased risk of ovarian cancer and diabetes mellitus (6, 35). Prevalence of gastric cancer, pancreatic cancer and salivary gland tumors is higher in “A” blood group (36-38). “O” blood group individuals are known to have a higher risk of cholera, gastro-intestinal infection with E. coli, peptic ulcer, duodenal ulcer, chronic myelocytic leukemia, acute lymphocytic leukemia and thalassemia (39-44). HTLV-1, cervical carcinoma and pulmonary tuberculosis have reported to be more common in persons with blood group “AB” (45-47). On the other hand, some studies demonstrated association of specific blood groups and resistance to certain infections for example blood groups “O” and “B” are associated with resistance to small pox (48), blood group “Pk” is associated with resistance to HIV-1 (49) and the absence of the Duffy blood group is associated with resistance to Plasmodium vivax (6). In the present study, a significant association between HBV with ABO and Rh blood groups was observed. This is comparable with previous findings (50), but it differs with other studies (51–54). Our results show that the presence of “O” blood group may significantly decrease the risk of hepatitis B and the distribution of Rh in HBV infected individuals was higher between Rh positive donors. In similar finding that performed on patients with hepatitis B in the hemodialysis center (55), blood group “O” was more frequent among people with HBV, but in their study it was not significant association between O blood group and HBV (56). In another study, higher frequency of blood group ‘‘B” in HBV infected patients was reported but there was no significant correlation between HBV infection and blood groups (51). In one study about patients with chronic hepatitis B, individuals with blood group “A” compared with other blood groups had higher serum bilirubin level, prothrombin time and higher risk of Hepato-cellular carcinoma and significant association was found between the presence of HBe Ag and blood groups (57). Meo et al. showed a significant association between hepatitis B and secretor status (58). We did not find any association between sero-positivity of HCV and ABO/Rh antigens. This is in concurrence with previous reports (59). However, in some studies, with less population, a significant association between blood groups and hepatitis C was reported (60-61). In a systematic review on 14 papers there was no significant association between four types of blood groups and HCV infection (62). In a study on patients with chronic hepatitis C infection, it was observed that non-O blood group was associated with increased severity of fibrosis (63). In the present study, there was a significant association between HIV infection and blood groups. Blood group ‘‘A” was the commonest blood group in HIV infected patients and percentage of HIV (Ag/Ab) was lower in donors who has blood group “B”. The similar results were reported by Amidu, et al. (64). In one study patients who were HIV sero-positive, “O positive” was the most prevalent blood group and “AB negative” blood group was the least prevalent (65). In Nigeria in pregnant women, the prevalence of blood group “O positive” was higher than in the general population (66). Farhud et al. showed a significant decrease of “B” blood group in anti-HIV positive individuals (67). A study in UK showed that ABO histo-blood group sugars were detected on the viral envelope protein, gp120. Thus incorporation of ABO antigens by HIV-1 may affect transmission of virus between individuals of discordant blood groups by interaction with host natural antibody and complement (68). We found no significant association between syphilis infection and blood groups in this study, similar to previous finding (52). In other study there was no association between syphilis and blood groups (69). In our study the prevalence of hepatitis B, hepatitis C, HIV, and syphilis infections was higher in subjects with RhD+, one reason for this, is the higher prevalence of RhD+ in the population of blood donors. The mechanism between blood type and infections remained undefined, which may be related to red cell immune adherence function among persons with different blood types (70). As the Swedish researchers investigated cell surface–expressed Pk in HIV infection and concluded that Pk expression strongly influences susceptibility to HIV-1 infection, which implicates Pk as a new endogenous cell-surface factor that may provide protection against HIV-1 infection and showed that Individuals with high Pk levels exhibited a greater natural resistance to HIV infection, (49) ABO and Rh blood groups polymorphisms may be involved in viral transmission. This study also justifies the statement that “in any country, as the proportion of the population with infectious diseases, such as HIV and hepatitis, increase the proportion of the population who are eligible to donate blood falls (71).

Conclusion

From the above data it is evident that blood group type of an individual does have some biological role in case of hepatitis B and HIV infections. Further studies regard in association of HBV and HIV infections with blood groups in different communities and even in national level is necessary to get more knowledge about this aspect.

Ethical considerations

Ethical issues (Including plagiarism, Informed Consent, misconduct, data fabrication and/or falsification, double publication and/or submission, redundancy, etc) have been completely observed by the authors.
  43 in total

1.  Terminology for blood group antigens and genes-historical origins and guidelines in the new millennium.

Authors:  G Garratty; W Dzik; P D Issitt; D M Lublin; M E Reid; T Zelinski
Journal:  Transfusion       Date:  2000-04       Impact factor: 3.157

2.  Transmission of hepatitis-B virus through salivary blood group antigens in saliva.

Authors:  Sultan Ayoub Meo; Ayman Assad Assad; Faisal M Sanie; Nawab Din Baksh; Ahmed Al-Qahtani; Zahoor Ali Shaikh
Journal:  J Coll Physicians Surg Pak       Date:  2010-07       Impact factor: 0.711

3.  Prevalence of antibody to hepatitis C virus in a blood donor population.

Authors:  C Richards; P Holland; K Kuramoto; C Douville; R Randell
Journal:  Transfusion       Date:  1991-02       Impact factor: 3.157

4.  HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation.

Authors:  Stuart J D Neil; Aine McKnight; Kenth Gustafsson; Robin A Weiss
Journal:  Blood       Date:  2005-02-22       Impact factor: 22.113

Review 5.  The genetic basis of the Rh blood group system.

Authors:  P L Mollison
Journal:  Transfusion       Date:  1994-06       Impact factor: 3.157

6.  The prevalence of hepatitis B surface antigen and its antibody in blood donors and high risk groups in Iran.

Authors:  H Farzadegan; C Harbour; F Ala
Journal:  Vox Sang       Date:  1979       Impact factor: 2.144

Review 7.  Blood groups and susceptibility to virus infection: new developments.

Authors:  Donald R Branch
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

8.  Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus among blood donors, Phitsanulok Regional Blood Center, Thailand.

Authors:  Pipat Luksamijarulkul; Nantaporn Thammata; Mujarin Tiloklurs
Journal:  Southeast Asian J Trop Med Public Health       Date:  2002-06       Impact factor: 0.267

9.  Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria.

Authors:  Fiekumo Igbida Buseri; Musa Abidemi Muhibi; Zaccheaus Awortu Jeremiah
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

Review 10.  Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis.

Authors:  Xiaofei Gao; Qian Cui; Xiang Shi; Jing Su; Zhihang Peng; Xin Chen; Na Lei; Keqin Ding; Lu Wang; Rongbin Yu; Ning Wang
Journal:  BMC Infect Dis       Date:  2011-04-09       Impact factor: 3.090

View more
  10 in total

Review 1.  ABO blood group and COVID-19: an updated systematic literature review and meta-analysis.

Authors:  Massimo Franchini; Mario Cruciani; Carlo Mengoli; Giuseppe Marano; Fabio Candura; Nadia Lopez; Ilaria Pati; Simonetta Pupella; Vincenzo De Angelis
Journal:  Blood Transfus       Date:  2021-05-12       Impact factor: 3.443

Review 2.  The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses.

Authors:  Sarwat Mahmud; Vajiheh Akbarzadeh; Laith J Abu-Raddad
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

3.  ABO blood groups and hepatitis B virus infection: a systematic review and meta-analysis.

Authors:  Wenzhan Jing; Siyu Zhao; Jue Liu; Min Liu
Journal:  BMJ Open       Date:  2020-02-02       Impact factor: 2.692

4.  Prevalence and Association of Transfusion Transmitted Infections with ABO and Rh Blood Groups among Blood Donors at the National Blood Bank, Amman, Jordan.

Authors:  Amir M Al Hroob; Sultan A M Saghir; Amer A Almaiman; Omar S A Alsalahi; Abdullah S Al-Wajeeh; Omar Y A Al-Shargi; Nader Al-Balagi; Ayman M Mahmoud
Journal:  Medicina (Kaunas)       Date:  2020-12-16       Impact factor: 2.430

5.  Susceptibility of ABO blood group to COVID-19 infections: clinico-hematological, radiological, and complications analysis.

Authors:  Saeed M Kabrah; Samer S Abuzerr; Mohammed A Baghdadi; Ahmed M Kabrah; Arwa F Flemban; Fayez S Bahwerth; Hamza M Assaggaf; Eisa A Alanazi; Abdullah A Alhifany; Sarah A Al-Shareef; Wesam H Alsabban; Anmar A Khan; Hissah Alzhrani; Layal K Jambi; Radi T Alsafi; Akhmed Aslam; Hebah M Kabrah; Ahmad O Babalghith; Amr J Halawani
Journal:  Medicine (Baltimore)       Date:  2021-12-30       Impact factor: 1.889

6.  ABO Blood Group and Outcomes in Patients with COVID-19 Admitted in the Intensive Care Unit (ICU): A Retrospective Study in a Tertiary-Level Hospital in Bangladesh.

Authors:  Mohammad Rabiul Halim; Shuvajit Saha; Injamam Ull Haque; Sadia Jesmin; Rahatul Jannat Nishat; A S M D Ashraful Islam; Seema Roy; Miah Md Akiful Haque; Md Motiul Islam; Tarikul Hamid; Kazi Nuruddin Ahmed; Md Azharul Islam Talukder; Arif Ahmed; Emran Hasan; Nurjahan Ananna; Faroque Md Mohsin; Mohammad Delwer Hossain Hawlader
Journal:  J Multidiscip Healthc       Date:  2021-09-02

7.  Magnitude and trend of HIV and Treponema pallidum infections among blood donors in Offinso-North District, Ghana: a nine-year retrospective, cross-sectional study.

Authors:  Charles Nkansah; Dorcas Serwaa; Felix Osei-Boakye; Richard Owusu-Ampomah
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

8.  Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan.

Authors:  Qian Fan; Wei Zhang; Bo Li; De-Jia Li; Jian Zhang; Fang Zhao
Journal:  Front Cell Infect Microbiol       Date:  2020-07-21       Impact factor: 5.293

9.  Clinical and hematological features among β-thalassemia major patients in Jazan region: A hospital-based study.

Authors:  Mohammed Mansour Khawaji; Ahmad Ali Hazzazi; Mohssen Hassen Ageeli; Yahya Hassan Mawkili; Abdulrahman Hussain Darbashi; Anwar Mohammed Ali Abo Kathiyah; Rehab Abdalrhman Humedi
Journal:  J Family Med Prim Care       Date:  2020-01-28

10.  The Potential Impact of Blood System on Dietary Habits and Smoking.

Authors:  Ioannis Tsamesidis; Evangelia Stalika; Chinedu O Egwu; Agathi Pritsa; Maria Parpori; Argyrios Gkinoudis; Diana Samara; Evgenia Lymperaki
Journal:  Medicines (Basel)       Date:  2022-01-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.